Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.

J Urol. 2019 Mar;201(3):528-534. doi: 10.1097/JU.0000000000000071.

PMID:
30759696
2.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11.

PMID:
30322661
3.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.

J Urol. 2018 Oct 9. pii: S0022-5347(18)43963-8. doi: 10.1016/j.juro.2018.10.001. [Epub ahead of print]

PMID:
30316897
4.

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL, Jagsi R.

Pract Radiat Oncol. 2018 May - Jun;8(3):145-152. doi: 10.1016/j.prro.2018.01.012. Epub 2018 Mar 12.

PMID:
29545124
5.

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, Lally BE, Latzka K, Lo SS, Moghanaki D, Movsas B, Rimner A, Roach M, Rodrigues G, Shirvani SM, Simone CB 2nd, Timmerman R, Daly ME.

Pract Radiat Oncol. 2017 Sep - Oct;7(5):295-301. doi: 10.1016/j.prro.2017.04.014. Epub 2017 Jun 5.

PMID:
28596092
6.

Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer.

Teh BS, Lewis GD, Mai W, Pino R, Ishiyama H, Butler EB.

Cancer Commun (Lond). 2018 Apr 17;38(1):11. doi: 10.1186/s40880-018-0281-4.

7.

Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline.

Moeller B, Balagamwala EH, Chen A, Creach KM, Giaccone G, Koshy M, Zaky S, Rodrigues G.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):245-250. doi: 10.1016/j.prro.2018.02.009. Epub 2018 Apr 4.

PMID:
29625898
8.

Systematic review of hypofractionated radiation therapy for prostate cancer.

Zaorsky NG, Ohri N, Showalter TN, Dicker AP, Den RB.

Cancer Treat Rev. 2013 Nov;39(7):728-36. doi: 10.1016/j.ctrv.2013.01.008. Epub 2013 Mar 1. Review.

9.
10.

Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.

Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Eisenbeisz E, Larson GL.

Am J Clin Oncol. 2018 Feb;41(2):115-120. doi: 10.1097/COC.0000000000000241.

PMID:
26523442
11.

Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.

Kaidar-Person O, Roach M 3rd, Créhange G.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):600-5. doi: 10.1016/j.ijrobp.2013.02.006. Epub 2013 Mar 20. Review.

PMID:
23523182
12.

Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.

Tramacere F, Arcangeli S, Pignatelli A, Castagna R, Portaluri M.

Anticancer Res. 2015 May;35(5):3049-54.

PMID:
25964594
13.

What is the best way to radiate the prostate in 2016?

Moon DH, Efstathiou JA, Chen RC.

Urol Oncol. 2017 Feb;35(2):59-68. doi: 10.1016/j.urolonc.2016.06.002. Epub 2016 Jul 6. Review.

PMID:
27395453
14.

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.

Nakamura K, Ikeda I, Inokuchi H, Takayama K, Inoue T, Kamba T, Ogawa O, Hiraoka M, Mizowaki T.

J Radiat Res. 2018 Sep 1;59(5):656-663. doi: 10.1093/jrr/rry060.

15.

A systematic review of hypofractionation for primary management of prostate cancer.

Koontz BF, Bossi A, Cozzarini C, Wiegel T, D'Amico A.

Eur Urol. 2015 Oct;68(4):683-91. doi: 10.1016/j.eururo.2014.08.009. Epub 2014 Sep 22. Review.

PMID:
25171903
16.

Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.

Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R.

Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1.

PMID:
30483899
17.

Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, Petit J, Chao ST, Brown PD, Vogelbaum M, Reardon DA, Chakravarti A, Wen PY, Chang E.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-25. doi: 10.1016/j.prro.2016.03.007. Epub 2016 Mar 31.

PMID:
27211230
18.

Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.

Yamazaki H, Nakamura S, Suzuki G, Yoshida K, Yoshioka Y, Koizumi M, Ogawa K.

Anticancer Res. 2015 Oct;35(10):5167-77. Review.

PMID:
26408674
19.

Hypofractionated radiotherapy for localized prostate cancer.

Höcht S, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Hölscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T.

Strahlenther Onkol. 2017 Jan;193(1):1-12. doi: 10.1007/s00066-016-1041-5. Epub 2016 Sep 14. Review. Erratum in: Strahlenther Onkol. 2016 Nov;192(11):830.

20.

ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.

Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS.

Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65. Review.

PMID:
22101389

Supplemental Content

Support Center